Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Scheller

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Parkinson'S Disease|April 1, 2016
Parkinson's Inside OutJon Stamford, Dieter Scheller, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|November 15, 2011
Mechanisms underlying and medical management of L-Dopa-associated motor complicationsManfred Gerlach, Peter Riederer, Dieter Scheller
British Journal of Pharmacology|October 24, 2014
Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptorsMartyn Wood, Vanessa Dubois, Dieter Scheller, et al.
The Journal of Organic Chemistry|September 13, 2003
Selectivity in the photodimerization of 6-alkylcoumarinsXiuling Yu, Dieter Scheller, Otto Rademacher, et al.
Plos One|December 17, 2014
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's diseaseAnne Michel, Patrick Downey, Jean-Marie Nicolas, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 19, 2006
Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detectionJan Kehr, Xiao-Jing Hu, Takashi Yoshitake, et al.
European Journal of Pharmacology|February 29, 2008
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the ratDieter Scheller, Nick Dürmüller, Paul Moser, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 16, 2008
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's diseaseDieter Scheller, Christoph Ullmer, Reinhard Berkels, et al.
Folia Neuropathologica|August 15, 2014
Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell cultureKhaled Radad, Dieter Scheller, Wolf-Dieter Rausch, et al.
European Journal of Pharmacology|December 25, 2013
Rotigotine protects against glutamate toxicity in primary dopaminergic cell cultureSandra Oster, Khaled Radad, Dieter Scheller, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Parkinson'S Disease|April 1, 2016
Parkinson's Inside OutJon Stamford, Dieter Scheller, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|November 15, 2011
Mechanisms underlying and medical management of L-Dopa-associated motor complicationsManfred Gerlach, Peter Riederer, Dieter Scheller
British Journal of Pharmacology|October 24, 2014
Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptorsMartyn Wood, Vanessa Dubois, Dieter Scheller, et al.
The Journal of Organic Chemistry|September 13, 2003
Selectivity in the photodimerization of 6-alkylcoumarinsXiuling Yu, Dieter Scheller, Otto Rademacher, et al.
Plos One|December 17, 2014
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's diseaseAnne Michel, Patrick Downey, Jean-Marie Nicolas, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 19, 2006
Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detectionJan Kehr, Xiao-Jing Hu, Takashi Yoshitake, et al.
European Journal of Pharmacology|February 29, 2008
Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep-wake cycle in the ratDieter Scheller, Nick Dürmüller, Paul Moser, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 16, 2008
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's diseaseDieter Scheller, Christoph Ullmer, Reinhard Berkels, et al.
Folia Neuropathologica|August 15, 2014
Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell cultureKhaled Radad, Dieter Scheller, Wolf-Dieter Rausch, et al.
European Journal of Pharmacology|December 25, 2013
Rotigotine protects against glutamate toxicity in primary dopaminergic cell cultureSandra Oster, Khaled Radad, Dieter Scheller, et al.
Pageof 2